Overview

Combination of Intravitreal Ranibizumab With or Without Macular Laser Photocoagulation for ME Secondary to BRVO

Status:
Completed
Trial end date:
2019-01-28
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of laser photocoagulation combined with ranibizumab intravitreal injection in macular edema (ME) secondary to branch retinal vein occlusion (BRVO) in long term.
Phase:
N/A
Details
Lead Sponsor:
Beijing Hospital
Treatments:
Ranibizumab